Overall rank by patents
#20,421
Across all tracked assignees
USPTO PatentsView assignee record - 14 granted patents across 6 technology areas, active 2015–2018. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B60D (VEHICLE CONNECTIONS).
The verdict
Scambia holds 14 US patents across 6 technology areas, rank #20,421 of 50,000 tracked assignees.
Scambia Holdings Cyprus Limited has been granted 14 US utility patents between 2015 and 2018, placing Scambia Holdings Cyprus Limited at rank #20,421 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 26.8 claims per patent with primary concentration in B60D (VEHICLE CONNECTIONS). As a Foreign Corporation, Scambia Holdings Cyprus Limited is one of the more focused assignees in the PatentsView dataset. By volume, Scambia sits between Samantree Medical Sa (14 patents, rank #20,417) and School Corporation, Azabu Veterinary Medicine Educational Institution (14 patents, rank #20,425) - the closest US assignees by grant volume. The composite Innovation Score of 33.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 14 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Scambia Holdings Cyprus Limited's 26.8 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Scambia Holdings Cyprus Limited against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SamanTree Medical SA
14 patents
Sami-Sabinsa Group Limited
14 patents
Samsung E&A Co., Ltd.
14 patents
Saurer Intelligent Technology AG
14 patents
Schaft Inc.
14 patents
Schaublin SA
14 patents
Schneider Electric Automation GmbH
14 patents
School Corporation, Azabu Veterinary Medicine Educational Institution
14 patents
Scambia Holdings Cyprus Limited
14 patents
What this shows Scambia holds 14 patents at rank #20,421, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #20,421 in granted patent volume.
Other assignees with the most granted patents in Scambia's primary technology class.
Scambia's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
33 Top 57% higher than 43% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 35.7% |
| 2016 | 2 | 14.3% |
| 2017 | 4 | 28.6% |
| 2018 | 3 | 21.4% |
Top 6 of 6 technology areas
Overall rank by patents
#20,421
Across all tracked assignees
33.0 out of 100
How to use this portfolio
Scambia's 14 grants land it in the top 57% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.